(Q37819494)

23 August 2017

1 reference

title

Registries in systemic sclerosis: a worldwide experience (English)

1 reference

23 August 2017

14

Ulf Müller-Ladner

1 reference

23 August 2017

Marco Matucci-Cerinic

15

object named as

Marco Matucci-Cerinic

0 references

Pia Moinzadeh

4

object named as

Pia Moinzadeh

1 reference

23 August 2017

Felice Galluccio

1

1 reference

23 August 2017

Ulrich A Walker

2

1 reference

23 August 2017

Svetlana Nihtyanova

3

1 reference

23 August 2017

Nicholas Hunzelmann

5

1 reference

23 August 2017

Thomas Krieg

6

1 reference

23 August 2017

Virginia Steen

7

1 reference

23 August 2017

Murray Baron

8

1 reference

23 August 2017

Percival Sampaio-Barros

9

1 reference

23 August 2017

Cristiane Kayser

10

1 reference

23 August 2017

Peter Nash

11

1 reference

23 August 2017

Chris P Denton

12

1 reference

23 August 2017

Alan Tyndall

13

1 reference

23 August 2017

publication date

1 January 2011

1 reference

23 August 2017

1 reference

23 August 2017

volume

50

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

60-68

1 reference

Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Scleroderma renal crisis: patient characteristics and long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Quality of life in patients with systemic sclerosis compared to the general population and patients with other chronic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

The relationship of dyspnoea to function and quality of life in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Prevalence and clinical correlates of pruritus in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

The cost of systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Demographic and clinical factors associated with physician service use in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Systemic sclerosis in Europe: first report from the EULAR Scleroderma Trials And Research (EUSTAR) group database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Clinical Correlates of Self-reported Physical Health Status in Systemic Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

Work Disability in Systemic Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEQ355

10.1093/RHEUMATOLOGY/KEQ355

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference